menu
Showcases Stock ranks

Bristol-Myers Squibb Company (BMY)
52.12 -1.52 (-2.83%) 12-14 16:02
Open: 53.21 Pre. Close: 53.64
High: 53.26 Low: 51.93
Volume: 10,708,011 Market Cap: 85070M
Share on Facebook   Tweet this page   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 53.317 - 53.623 53.623 - 53.899
Low: 51.24 - 51.572 51.572 - 51.871
Close: 51.654 - 52.184 52.184 - 52.663
Stock Technical Analysis
Overall:     
Target: Six months: 61.81
One year: 64.02
Support: Support1: 49.86
Support2: 41.48
Resistance: Resistance1: 52.92
Resistance2: 54.81
Pivot: 52.66
Moving Averages: MA(5): 52.84
MA(20): 52.87
MA(100): 57.16
MA(250): 58.21
MACD: MACD(12,26): -0.21
Signal(12,26,9): -0.34
%K %D: %K(14,3): 73.12
%D(3): 71.54
RSI: RSI(14): 45.06
52-Week: High: 70.05
Low: 46.94
Change(%): -16.5
Average Vol(K): 3-Month: 879449
10-Days: 910489
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

BMY has closed above bottom band by 31.0%. Bollinger Bands are 42.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMY's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
2018-12-15T05:31:46-05:00
Nicholas Ward's Dividend Growth Portfolio: November Update

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1632.20
Shares Float (M) 1625.96
% Held by Insiders 0.40
% Held by Institutions 109.50
Shares Short (K) 11924
Shares Short Prior Month (K)
Stock Financials
EPS 3.720
EPS Est. Current Year 3.000
EPS Est. Next Year 3.230
EPS Est. Next Quarter 0.790
Forward EPS 3.720
Book Value (p.s.) 6.370
PEG Ratio 1.25
Profit Margin 6.98
Operating Margin 27.26
Return on Assets (ttm) 4.2
Return on Equity (ttm) 10.1
Qtrly Rev. Growth 8.3
Gross Profit (p.s.) 2.313
Sales Per Share
EBITDA (p.s.) 0.580
Qtrly Earnings Growth 125.00
Operating Cash Flow (M) 4630.00
Levered Free Cash Flow (M) 3260.00
Stock Valuation
P/E 14.01
P/E Growth Ratio -0.03
P/BV 8.18
P/S 6298880512.00
P/CF 18.38
Dividend Yield 0.06
Dividends & Splits
Dividend 3.090
Dividend Pay Date 2018-11-01
Ex-Dividend Date 2018-10-04
Forward Dividend 1.600
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator